Logo image of MSS

MAISON SOLUTIONS INC-A (MSS) Stock Fundamental Analysis

NASDAQ:MSS - US5606671072 - Common Stock

0.928 USD
+0.04 (+3.94%)
Last: 8/29/2025, 8:00:01 PM
0.9504 USD
+0.02 (+2.41%)
After Hours: 8/29/2025, 8:00:01 PM
Fundamental Rating

3

MSS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. MSS may be in some trouble as it scores bad on both profitability and health. MSS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MSS was profitable.
In the past year MSS had a positive cash flow from operations.
In multiple years MSS reported negative net income over the last 5 years.
MSS had a positive operating cash flow in 4 of the past 5 years.
MSS Yearly Net Income VS EBIT VS OCF VS FCFMSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 2M -2M 4M -4M -6M

1.2 Ratios

With a Return On Assets value of 1.51%, MSS is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
The Return On Equity of MSS (10.02%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.51%
ROE 10.02%
ROIC N/A
ROA(3y)0.36%
ROA(5y)0.56%
ROE(3y)72.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSS Yearly ROA, ROE, ROICMSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

MSS has a Profit Margin of 0.94%. This is comparable to the rest of the industry: MSS outperforms 41.46% of its industry peers.
MSS has a Gross Margin (21.21%) which is in line with its industry peers.
In the last couple of years the Gross Margin of MSS has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 0.94%
GM 21.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.41%
GM growth 5YN/A
MSS Yearly Profit, Operating, Gross MarginsMSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

MSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MSS has about the same amount of shares outstanding.
Compared to 1 year ago, MSS has an improved debt to assets ratio.
MSS Yearly Shares OutstandingMSS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M 15M
MSS Yearly Total Debt VS Total AssetsMSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

MSS has an Altman-Z score of 1.54. This is a bad value and indicates that MSS is not financially healthy and even has some risk of bankruptcy.
MSS has a Altman-Z score of 1.54. This is in the lower half of the industry: MSS underperforms 75.61% of its industry peers.
The Debt to FCF ratio of MSS is 2.25, which is a good value as it means it would take MSS, 2.25 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 2.25, MSS is doing good in the industry, outperforming 70.73% of the companies in the same industry.
MSS has a Debt/Equity ratio of 0.88. This is a neutral value indicating MSS is somewhat dependend on debt financing.
The Debt to Equity ratio of MSS (0.88) is worse than 60.98% of its industry peers.
Even though the debt/equity ratio score it not favorable for MSS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 2.25
Altman-Z 1.54
ROIC/WACCN/A
WACC7.98%
MSS Yearly LT Debt VS Equity VS FCFMSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

MSS has a Current Ratio of 0.57. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSS has a Current ratio of 0.57. This is amonst the worse of the industry: MSS underperforms 92.68% of its industry peers.
MSS has a Quick Ratio of 0.57. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSS's Quick ratio of 0.32 is on the low side compared to the rest of the industry. MSS is outperformed by 75.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.32
MSS Yearly Current Assets VS Current LiabilitesMSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

MSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 138.46%, which is quite impressive.
The Revenue has grown by 114.02% in the past year. This is a very strong growth!
Measured over the past years, MSS shows a very strong growth in Revenue. The Revenue has been growing by 43.56% on average per year.
EPS 1Y (TTM)138.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.33%
Revenue 1Y (TTM)114.02%
Revenue growth 3Y43.56%
Revenue growth 5YN/A
Sales Q2Q%73.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSS Yearly Revenue VS EstimatesMSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.26 indicates a correct valuation of MSS.
MSS's Price/Earnings ratio is a bit cheaper when compared to the industry. MSS is cheaper than 78.05% of the companies in the same industry.
MSS is valuated cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.26
Fwd PE N/A
MSS Price Earnings VS Forward Price EarningsMSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MSS indicates a rather cheap valuation: MSS is cheaper than 92.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.99
EV/EBITDA N/A
MSS Per share dataMSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAISON SOLUTIONS INC-A

NASDAQ:MSS (8/29/2025, 8:00:01 PM)

After market: 0.9504 +0.02 (+2.41%)

0.928

+0.04 (+3.94%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.62%
Inst Owner Change-3.83%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.27M
AnalystsN/A
Price TargetN/A
Short Float %1.66%
Short Ratio1.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.26
Fwd PE N/A
P/S 0.15
P/FCF 3.99
P/OCF 3.84
P/B 1.57
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.07
EY7.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.23
FCFY25.07%
OCF(TTM)0.24
OCFY26.03%
SpS6.31
BVpS0.59
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 10.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.94%
GM 21.21%
FCFM 3.69%
ROA(3y)0.36%
ROA(5y)0.56%
ROE(3y)72.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.41%
GM growth 5YN/A
F-Score7
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 2.25
Debt/EBITDA N/A
Cap/Depr 16.94%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 391.76%
Current Ratio 0.57
Quick Ratio 0.32
Altman-Z 1.54
F-Score7
WACC7.98%
ROIC/WACCN/A
Cap/Depr(3y)250.54%
Cap/Depr(5y)154.53%
Cap/Sales(3y)1.99%
Cap/Sales(5y)1.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)138.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)114.02%
Revenue growth 3Y43.56%
Revenue growth 5YN/A
Sales Q2Q%73.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.02%
FCF growth 3Y47.63%
FCF growth 5YN/A
OCF growth 1Y235.76%
OCF growth 3Y47.32%
OCF growth 5YN/A